Copyright
©The Author(s) 2025.
World J Gastroenterol. May 28, 2025; 31(20): 105554
Published online May 28, 2025. doi: 10.3748/wjg.v31.i20.105554
Published online May 28, 2025. doi: 10.3748/wjg.v31.i20.105554
Table 4 Diagnostic performance of magnetic resonance parameters in the assessment of liver fibrosis
| Parameters | T1pre (ms) | △T1 (ms) | ADC (× 10-3, mm2/second) | T2 | Combined diagnosis |
| AUC | 0.926 | 0.961 | 0.809 | 0.926 | 0.989 |
| 95%CI | 0.902-0.951 | 0.945-0.976 | 0.768-0.851 | 0.899-0.953 | 0.982-0.996 |
| P value | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
| Sensitivity | 0.889 | 0.898 | 0.810 | 0.829 | 0.940 |
| Specificity | 0.852 | 0.907 | 0.708 | 0.940 | 0.977 |
- Citation: Lyu SY, Xiao W, Chen YJ, Liao QL, Cai YY, Yu C, Liu JY, Liu H, Zhang MP, Ren YL, Yu QL, Qi YM, Xiao EH, Luo YH. Multi-parameter magnetic resonance imaging of zebularine in liver fibrosis treatment and calcineurin/NFAT3 mechanism. World J Gastroenterol 2025; 31(20): 105554
- URL: https://www.wjgnet.com/1007-9327/full/v31/i20/105554.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i20.105554